Abstract:Epidemiologic studies report lower rates of cardiovascular disease in Asian populations where soy products are a staple food. Soy protein consumption has been shown to reduce non‐HDL cholesterol and is the richest dietary source of isoflavones (phytoestrogens), a group of bioactive compounds also shown to have potentially favorable effects on CVD risk. We are conducting a randomized, three‐period, double blind crossover study designed to evaluate the effects of soy protein supplementation on HDL function (measured via cholesterol efflux), central blood pressure and indices of arterial stiffness. Healthy males and females 35–60 years of age with systolic blood pressure ≥120 mm Hg and/or diastolic blood pressure ≥80 mm Hg were recruited. The three dietary treatments are: A) 25 g/d soy protein isolate (SPI); B) 50 g/d SPI; and C) 0 g/d SPI (isocaloric carbohydrate control). Participants were free living and followed their habitual diets to which they incorporated the SPI or control powders mixed with milk or water twice daily for 6 weeks each followed by a 2‐week break between treatments. Participants were instructed to keep their diet consistent during treatment periods and asked not to consume any soy containing products other than those provided. Three day dietary records were completed at baseline and during the last week of each treatment to ensure consistency in dietary intake. Participants reported to the diet center weekly to monitor body weight, review consumption logs and collect their soy (or control) powder. Twenty participants are included in the study; 18 have completed all study procedures and 2 will complete their final treatment period by December 2015. Baseline characteristics (mean ± SE) of participants (n=20; 9M & 11F) are as follows: age 51.9 ± 0.72 years, BMI 26.4 ± 0.1 kg/m 2 , systolic blood pressure 129.7 ± 1.9 mm Hg, diastolic blood pressure 82.5 ± 1.1 mm Hg, fasting glucose 88.7 ± 1.0 mg/dL, total cholesterol 197.3 ± 3.3 mg/dl, LDL‐C 120.3 ± 3.0 mg/dL and HDL‐C 55.3 ± 1.4 mg/dL. We hypothesize that consumption of soy protein (in a dose‐dependent manner) will favorably affect HDL particle size, increase HDL‐mediated ex vivo cholesterol efflux and improve central BP and arterial health in this normolipidemic, mildly hypertensive population. Support or Funding Information Sponsored by DuPont Nutrition & Health

Effects of soy protein isolate hydrolysates on cholecystokinin released by rat intestinal mucosal cells and food intake in rats

Characterization of the structure, antioxidant activity and hypoglycemic activity of soy (Glycine max L.) protein hydrolysates

Hypocholesterolemic Effects of Soy Protein Isolates from Soybeans Differing in 7S and 11S Globulin Subunits Vary in Rats Fed a High Cholesterol Diet

Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats

Soybean Protein Hydrolysate Stimulated Cholecystokinin Secretion and Inhibited Feed Intake Through Calcium-Sensing Receptors and Intracellular Calcium Signalling in Pigs

Effect of oat and soybean rich in distinct non-starch polysaccharides on fermentation, appetite regulation and fat accumulation in rat

Effects of Soy Protein on HDL‐C Function, Central Blood Pressure, and Arterial Stiffness: Study Design and Participant Characteristics

Effects of Plant Protein Isolate on Serum Lipids Metabolism in Ovariectomized Rats

Effect of non-covalent and covalent complexation of (−)-epigallocatechin gallate with soybean protein isolate on protein structure and in vitro digestion characteristics

Effect of glycosylation and limited hydrolysis on structural and functional properties of soybean protein isolate

Effects of soybean protein isolate − polyphenol conjugate formation on the protein structure and emulsifying properties: Protein − polyphenol emulsification performance in the presence of chitosan

Soy Protein Increases Cognitive Level in Mice by Modifying Hippocampal Nerve Growth, Oxidative Stress, and Intestinal Microbiota

Soy protein isolate-catechin non-covalent and covalent complexes: Focus on structure, aggregation, stability and in vitro digestion characteristics

The anti-digestibility mechanism of soy protein isolate hydrolysate on natural starches with different crystal types

Soy protein compared with whey protein ameliorates insulin resistance by regulating lipid metabolism, AMPK/mTOR pathway and gut microbiota in high-fat diet-fed mice

Increasing Intestinal Soy Protein Hydrolysate Levels Promotes Colon Inflammation by Affecting Microbial Metabolism and Increases the Protein Expression of Colonic Tight Junction Proteins

Investigation of the Differences in the Effect of (−)-Epigallocatechin Gallate and Proanthocyanidins on the Functionality and Allergenicity of Soybean Protein Isolate

In Vitro Study on Digestibility of Soy Protein Isolates and Effects of Thermal Treatments

Physicochemical and Functional Properties of DND358 (A Hypocholesterolemic Soybean) Protein Isolate

Effects of soy hull polysaccharide on dyslipidemia and pathoglycemia in rats induced by a high-fat-high-sucrose diet

Effects of Soy Isoflavone on Hepatic Fatty Acid Metabolism of Rats